Horizon Health International Corp. Announces a Two-Hundred-For-One Stock Split
December 15 2010 - 4:10PM
Marketwired
HORIZON HEALTH INTERNATIONAL CORP. (PINK SHEETS: HZHI) (the
Company) announced today that the Company's stockholders have
approved a Two Hundred-for-One reverse stock split (Reverse Split)
effective on the opening of trading December 16, 2010 under the
symbol 'HZHID'.
The Company was notified by FINRA that effective October 16,
2010 a "D" will be placed on the ticker symbol "HZHID" for 20
business days, thereafter the symbol will revert back to the
original symbol "HZHI".
The new Cusip Number for the common stock will be
'44041J206'.
As a result of the Reverse Split every two hundred shares of the
Company that a stockholder owned were converted into one share of
the Company as of the opening of trading on January 16, 2010, the
effective date of the Reverse Split. Fractional Shares created as a
result of the Reverse Split will be rounded up to the nearest whole
share.
Mr. Rocco Di Fruscia, the Company's CEO, stated, "We had no
other alternative than to restructure the Company's outstanding
stock to attract investors, potential investment opportunities and
for the successful future development of the company."
About Horizon Health International Corp.
HORIZON's subsidiary 'New Release Lactoferrin Pharma Canada
Inc.' is an emerging specialty pharmaceutical company that is
committed to supply its patented delivery systems of enteric
lactoferrin, and "PEG-lactoferrin". We have already introduced
enteric lactoferrin products in the market as a supplemental food
and have also undertaken projects to further study these products
and increase their pharmaceutical applications. Since 2008, the
company's proprietary enteric lactoferrin has already earned top
market share amongst all lactoferrin-containing products.
Forward-looking statements in this release are made pursuant to
the "safe harbor" provisions of the Private Securities Litigation
Reform Act of 1995. Such forward-looking statements involve risks
and uncertainties, including, without limitation, continued
acceptance of the Company's products, increased levels of
competition, new products and technological changes, dependence
upon third-party suppliers, intellectual property rights, and other
risks detailed from time to time in the Company's periodic
reports.
Contacts: Horizon Health International Corp. Rocco Di Fruscia
President & CEO 514 586 3799 horizonhealth@shaw.ca
www.horizonhealthinternational.com
Horizon Health (CE) (USOTC:HZHI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Horizon Health (CE) (USOTC:HZHI)
Historical Stock Chart
From Apr 2023 to Apr 2024